Products Overview
| Therapeutic area | Product | Indication | Stage of development |
|---|---|---|---|
| Gastrointestinal | COLAL-PRED® (Norgine in Europe) | UC - treatment of active disease | Phase III completed |
| COLAL-PRED® (Prometheus in US) | UC - treatment of active disease | Phase II ongoing | |
| COLAL-PRED® (TSD in Japan) | UC - treatment of active disease | Phase I ongoing | |
| COLAL-PRED® | UC - maintenance of remission | Phase III ready | |
| Cancer supportive care | ATL-104 | Mucositis | Phase IIa completed |
Note: COLAL-PRED® is a registered trademark of Alizyme Therapeutics Limited